Menu

Topics

Connect

Comments

Comments closed.

Due to the sensitive and/or legal subject matter of some of the content on globalnews.ca, we reserve the ability to disable comments from time to time.

Please see our Commenting Policy for more.

Alberta researchers use special bubbles to deliver antirejection drugs after transplant

Health Matters September 11: The Canadian Institutes of Health Research has awarded funding to a University of Alberta team – to help develop special bubbles that deliver anti-rejection drugs to specific areas after transplant. As Su-Ling Goh reports, the technique has potential to change lives for patients with Type 1 diabetes.

Advertisement

More Videos

Advertisement

You are viewing an Accelerated Mobile Webpage.

View Original Article